Status:
COMPLETED
Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Kidney Transplantation
Eligibility:
All Genders
13-75 years
Phase:
PHASE4
Brief Summary
This study will determine which, if any, allelic variants of mycophenolic acid (MPA) metabolizing enzymes, drug transporters and drug targets are associated with the observed variation in pharmacokine...
Eligibility Criteria
Inclusion
- patients participating in study ML17225.
Exclusion
- N/A.
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT00337493
Start Date
December 1 2005
End Date
January 1 2008
Last Update
September 17 2012
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States, 35294
2
Little Rock, Arkansas, United States, 72205-7199
3
Los Angeles, California, United States, 90057
4
Denver, Colorado, United States, 80262